Abbott Launches TriClip Minimally Invasive Heart Valve Therapy in India

The minimally invasive device is designed as an alternative to open-heart surgery and is delivered through a vein in the leg.

Abbott has launched its TriClip transcatheter edge-to-edge repair (TEER) system in India for the treatment of tricuspid regurgitation (TR), a heart valve condition caused by leakage in the tricuspid valve.

The minimally invasive device is designed as an alternative to open-heart surgery and is delivered through a vein in the leg. The system works by clipping portions of the tricuspid valve leaflets together to improve valve closure and restore blood flow within the heart.

Abbott said the therapy is particularly intended for patients who are unsuitable for surgical intervention. According to the company, patients treated with TriClip generally require a hospital stay of about one day before discharge.

The TriClip system is based on Abbott’s MitraClip platform, which is used for mitral valve repair, but includes a specialized delivery mechanism designed specifically for the right side of the heart.

Tricuspid regurgitation occurs when the tricuspid valve does not close properly, allowing blood to flow backward inside the heart. The condition can lead to fatigue, shortness of breath, atrial fibrillation, and heart failure if left untreated.

Abbott said the condition is increasingly being identified in India, particularly among elderly patients and individuals with rheumatic heart disease, pulmonary hypertension, or other cardiovascular disorders.

Sudheer Mirajkar, Country Manager for Abbott’s Structural Heart business in India, said the launch expands treatment options for patients with limited surgical eligibility.

The launch comes amid growing adoption of catheter-based structural heart therapies in India, where demand for minimally invasive cardiac procedures has increased due to shorter recovery times and lower procedural risks compared to conventional surgery.

The TriClip system adds to Abbott’s structural heart portfolio in India, which includes devices focused on valve repair and cardiovascular interventions.

Stay tuned for more such updates on Digital Health News